132 related articles for article (PubMed ID: 27517621)
21. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
[TBL] [Abstract][Full Text] [Related]
22. EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.
Lasnon C; Quak E; Le Roux PY; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
EJNMMI Phys; 2017 Dec; 4(1):17. PubMed ID: 28560574
[TBL] [Abstract][Full Text] [Related]
23. Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0.
Kitajima K; Miyoshi Y; Yamano T; Odawara S; Higuchi T; Yamakado K
Nagoya J Med Sci; 2018 May; 80(2):183-197. PubMed ID: 29915436
[TBL] [Abstract][Full Text] [Related]
24. Early
Skougaard K; Nielsen D; Jensen BV; Pfeiffer P; Hendel HW
Acta Oncol; 2016; 55(9-10):1175-1182. PubMed ID: 27548393
[TBL] [Abstract][Full Text] [Related]
25. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
Shady W; Sotirchos VS; Do RK; Pandit-Taskar N; Carrasquillo JA; Gonen M; Sofocleous CT
AJR Am J Roentgenol; 2016 Sep; 207(3):661-70. PubMed ID: 27384594
[TBL] [Abstract][Full Text] [Related]
26. FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review.
Helland F; Hallin Henriksen M; Gerke O; Vogsen M; Høilund-Carlsen PF; Hildebrandt MG
Diagnostics (Basel); 2019 Aug; 9(3):. PubMed ID: 31461923
[TBL] [Abstract][Full Text] [Related]
27. Does PET SUV Harmonization Affect PERCIST Response Classification?
Quak E; Le Roux PY; Lasnon C; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
J Nucl Med; 2016 Nov; 57(11):1699-1706. PubMed ID: 27283930
[TBL] [Abstract][Full Text] [Related]
28. Comparing RECIST with EORTC criteria in metastatic bladder cancer.
Öztürk H
J Cancer Res Clin Oncol; 2016 Jan; 142(1):187-94. PubMed ID: 26208817
[TBL] [Abstract][Full Text] [Related]
29. Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer.
Sørensen JS; Vilstrup MH; Holm J; Vogsen M; Bülow JL; Ljungstrøm L; Braad PE; Gerke O; Hildebrandt MG
Diagnostics (Basel); 2020 Nov; 10(12):. PubMed ID: 33255442
[TBL] [Abstract][Full Text] [Related]
30. The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST.
Inno A; Lo Russo G; Salgarello M; Corrao G; Casolino R; Galli G; Modena A; Romano L; Pusceddu S; Greco FG; Garassino MC; Gori S
Tumori; 2018; 104(2):88-95. PubMed ID: 29714647
[TBL] [Abstract][Full Text] [Related]
31. The Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCIST.
Pinker K; Riedl CC; Ong L; Jochelson M; Ulaner GA; McArthur H; Dickler M; Gönen M; Weber WA
J Nucl Med; 2016 Jul; 57(7):1102-4. PubMed ID: 26985059
[TBL] [Abstract][Full Text] [Related]
32. PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
Fendler WP; Lehmann M; Todica A; Herrmann K; Knösel T; Angele MK; Dürr HR; Rauch J; Bartenstein P; Cyran CC; Hacker M; Lindner LH
J Nucl Med; 2015 Apr; 56(4):530-7. PubMed ID: 25722445
[TBL] [Abstract][Full Text] [Related]
33. Proposal of a new 18F-FDG PET/CT predictor of response in rectal cancer treated by neoadjuvant chemoradiation therapy and comparison with PERCIST criteria.
Maffione AM; Ferretti A; Chondrogiannis S; Rampin L; Marzola MC; Grassetto G; Capirci C; Colletti PM; Rubello D
Clin Nucl Med; 2013 Oct; 38(10):795-7. PubMed ID: 24107808
[TBL] [Abstract][Full Text] [Related]
34. Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.
Necib H; Garcia C; Wagner A; Vanderlinden B; Emonts P; Hendlisz A; Flamen P; Buvat I
J Nucl Med; 2011 Mar; 52(3):354-61. PubMed ID: 21345787
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
Martins EB; Chojniak R; Kowalski LP; Nicolau UR; Lima EN; Bitencourt AG
PLoS One; 2015; 10(11):e0140009. PubMed ID: 26562784
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST.
Vogsen M; Bülow JL; Ljungstrøm L; Oltmann HR; Alamdari TA; Naghavi-Behzad M; Braad PE; Gerke O; Hildebrandt MG
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33921580
[TBL] [Abstract][Full Text] [Related]
37. Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0.
O JH; Lodge MA; Wahl RL
Radiology; 2016 Aug; 280(2):576-84. PubMed ID: 26909647
[TBL] [Abstract][Full Text] [Related]
38. Complexity of Response Evaluation During Primary Systemic Therapy of Breast Cancer: Scoring Systems and Beyond-Preliminary Results.
Tőkés T; Szentmártoni G; Torgyík L; Somlai K; Kulka J; Lengyel Z; Györke T; Dank M
Anticancer Res; 2015 Sep; 35(9):5063-72. PubMed ID: 26254408
[TBL] [Abstract][Full Text] [Related]
39. PERCIST in Perspective.
O JH; Wahl RL
Nucl Med Mol Imaging; 2018 Feb; 52(1):1-4. PubMed ID: 29391906
[TBL] [Abstract][Full Text] [Related]
40. (18)F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer.
Metser U; Rashidi F; Moshonov H; Wong R; Knox J; Guindi M; Darling G
Ann Nucl Med; 2014 May; 28(4):295-303. PubMed ID: 24474598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
